First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

Detalles Bibliográficos
Autores principales: Hojjat-Farsangi, M., Daneshmanesh, A. H., Khan, A. S., Shetye, J., Mozaffari, F., Kharaziha, P., Rathje, L.-S., Kokhaei, P., Hansson, L., Vågberg, J., Byström, S., Olsson, E., Löfberg, C., Norström, C., Schultz, J., Norin, M., Olin, T., Österborg, A., Mellstedt, H., Moshfegh, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170396/
https://www.ncbi.nlm.nih.gov/pubmed/29725030
http://dx.doi.org/10.1038/s41375-018-0113-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170396/
https://www.ncbi.nlm.nih.gov/pubmed/29725030
http://dx.doi.org/10.1038/s41375-018-0113-1

Ejemplares similares